---
document_datetime: 2025-04-30 10:35:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/retsevmo-epar-all-authorised-presentations_en.pdf
document_name: retsevmo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.379576
conversion_datetime: 2025-12-23 03:56:53.068053
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size    |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|--------------|
| EU/1/20/1527/001 | Retsevmo          | 40 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)             | 60 capsules  |
| EU/1/20/1527/002 | Retsevmo          | 80 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)             | 60 capsules  |
| EU/1/20/1527/003 | Retsevmo          | 80 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)             | 120 capsules |
| EU/1/20/1527/004 | Retsevmo          | 40 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 14 capsules  |
| EU/1/20/1527/005 | Retsevmo          | 40 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 42 capsules  |
| EU/1/20/1527/006 | Retsevmo          | 40 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 56 capsules  |
| EU/1/20/1527/007 | Retsevmo          | 40 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 168 capsules |
| EU/1/20/1527/008 | Retsevmo          | 80 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 14 capsules  |
| EU/1/20/1527/009 | Retsevmo          | 80 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 28 capsules  |
| EU/1/20/1527/010 | Retsevmo          | 80 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 56 capsules  |
| EU/1/20/1527/011 | Retsevmo          | 80 mg      | Capsule, hard         | Oral use                  | blister (PCTFE/PVC/alu)   | 112 capsules |
| EU/1/20/1527/012 | Retsevmo          | 40 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 30 tablets   |
| EU/1/20/1527/013 | Retsevmo          | 40 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 56 tablets   |
| EU/1/20/1527/014 | Retsevmo          | 40 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 60 tablets   |
| EU/1/20/1527/015 | Retsevmo          | 80 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 30 tablets   |
| EU/1/20/1527/016 | Retsevmo          | 80 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 56 tablets   |
| EU/1/20/1527/017 | Retsevmo          | 80 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 60 tablets   |
| EU/1/20/1527/018 | Retsevmo          | 120 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 30 tablets   |
| EU/1/20/1527/019 | Retsevmo          | 120 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 56 tablets   |
| EU/1/20/1527/020 | Retsevmo          | 120 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 60 tablets   |
| EU/1/20/1527/021 | Retsevmo          | 160 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 30 tablets   |
| EU/1/20/1527/022 | Retsevmo          | 160 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 56 tablets   |
| EU/1/20/1527/023 | Retsevmo          | 160 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu/OPA/alu) | 60 tablets   |